CLOV’s options market pricing reflects expectations of short-term volatility. Forecast probability models predict a 60% chance of testing the $1.65 level within two months. Looking ahead, sell-side analysts expect revenue to grow 31.2% over the next 12 months, an improvement versus the last two years. This projection is eye-popping and suggests its newer products and services will spur better top-line performance. TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions. According to multiple equity research updates, CLOV stock forecast benefits from operational cost controls and tech-driven efficiencies. Price models show fair value in the $1.55 zone under current macroeconomic assumptions.
